Inspire Medical Systems (INSP) Liabilities and Shareholders Equity (2017 - 2026)

Inspire Medical Systems has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $911.4 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $911.4 million, up 24.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 billion (up 11.91% YoY), and the FY2025 annual result was $907.3 million, up 12.24% from the prior year.
• Liabilities and Shareholders Equity came in at $911.4 million for Q1 2026 at Inspire Medical Systems, roughly flat from $907.3 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $911.4 million in Q1 2026 to a low of $289.7 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $685.8 million (2024), against an average of $668.2 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 111.73% in 2023 and advanced 1.45% in 2025, its largest moves.
• Inspire Medical Systems' Liabilities and Shareholders Equity stood at $564.9 million in 2022, then gained by 19.82% to $676.8 million in 2023, then climbed by 19.44% to $808.4 million in 2024, then rose by 12.24% to $907.3 million in 2025, then advanced by 0.45% to $911.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $911.4 million (Q1 2026), $907.3 million (Q4 2025), and $807.7 million (Q3 2025), per Business Quant data.